title: Influenza vaccine oculorespiratory syndrome incidence is reduced in HIV.
abstract: Clinical experience suggests Oculorespiratory Syndrome (ORS) following influenza vaccination is rare in HIV but this is not well evaluated. We assessed ORS incidence in a randomized influenza vaccine trial of HIV participants. The overall incidence was 0.8% suggesting that influenza vaccine ORS incidence is reduced in HIV.
authors.affiliation: University of Ottawa, The Ottawa Hospital Division of Infectious Diseases, Ottawa, Ontario, Canada. ccooper@ottawahospital.on.ca
authors.forename: Curtis
authors.initials: C
authors.lastname: Cooper
authors.forename: Anona
authors.initials: A
authors.lastname: Thorne
mesh_terms: D000293:Adolescent; D000328:Adult; D005128:Eye Diseases / Q000139:chemically induced* / Q000453:epidemiology* / Q000276:immunology; D005260:Female; D015658:HIV Infections / Q000276:immunology*; D006801:Humans; D015994:Incidence; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D012140:Respiratory Tract Diseases / Q000139:chemically induced* / Q000453:epidemiology* / Q000276:immunology; D055815:Young Adult
chemical_list: D007252:Influenza Vaccines